摘要
Severe acute respiratory syndrome coronavirus 2(SARS-Co V-2)has placed a heavy burden on the global healthcare system,especially in developing and underdeveloped countries where professionals and specialized laboratories are scarce.And due to the increased demand for large-scale detection and the shortage of animal models for vaccines and antiviral drugs under the coronavirus disease 2019(COVID-19)pandemic.
作者
Jiajia Liu
Youchun Xu
Jing Cheng
刘佳佳;徐友春;程京(State Key Laboratory of Membrane Biology,Department of Biomedical Engineering,School of Medicine,Tsinghua University,Beijing 100084,China;National Engineering Research Center for Beijing Biochip Technology,Beijing 102200,China)
基金
supported by the National Natural Science Foundation of China(31870853 and 82161138004)
Guangzhou Institute of Respiratory Health Open Project(funds provided by China Evergrande Group,2020GIRHHMS02)
Emergency Key Program of Guangzhou Laboratory(EKPG21-14)
Tsinghua University Spring Breeze Fund(20201080532)
Beijing Nova Program 2020,and Beijing Lab Foundation。
